Daniel Vitt - 02 Jan 2023 Form 4 Insider Report for IMMUNIC, INC. (IMUX)

Role
Chief Executive Officer, Director
Signature
/s/ Daniel Vitt
Issuer symbol
IMUX
Transactions as of
02 Jan 2023
Net transactions value
$0
Form type
4
Filing time
06 Jan 2023, 20:30:27 UTC
Previous filing
23 Nov 2022
Next filing
19 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMUX Stock Option Award $0 +300,000 $0.000000 300,000 02 Jan 2023 Common Stock 300,000 $1.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.